Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Arthritis, Rheumatoid

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Arthritis, Rheumatoid in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Snir, O1
Hesselberg, E1
Amoudruz, P1
Klareskog, L1
Zarea-Ganji, I1
Catrina, AI1
Padyukov, L1
Malmström, V1
Seddighzadeh, M1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Arthritis, Rheumatoid

ArticleYear
Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis.
    Genes and immunity, 2013, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amphetamines; Arthritis, Rheumatoid; Enterotoxins; Genetic Variation

2013